VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
Validity of self-report of lipid medication use: the Atherosclerosis Risk in Communities (ARIC) Study.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Validity of self-report of lipid medication use: the Atherosclerosis Risk in Communities (ARIC) Study.
Validity of self-report of lipid medication use: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 2015 Oct; 242(2):625-9.
View in:
PubMed
subject areas
Aged
Aged, 80 and over
Atherosclerosis
Female
Follow-Up Studies
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipids
Male
Middle Aged
Odds Ratio
Predictive Value of Tests
Prevalence
Prospective Studies
Reproducibility of Results
Self Report
Sensitivity and Specificity
Surveys and Questionnaires
United States
authors with profiles
CHRISTIE BALLANTYNE